Barclays upgrades Sanofi to Overweight

Barclays upgrades Sanofi to Overweight
Credit: © Reuters.

A Barclays analyst upgraded Sanofi (EPA: SASY) from Equalweight to Overweight with a price target of $115.00 from a prior price target of EUR90.00.

Prior to this rating, Sanofi had 15 buy ratings, 11 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on Sanofi, click here. For more news on Sanofi, click here.

Sanofi's stock price closed at $97.10. They are up 0% in the last month and up 4.82% in the last 12 months.

According to Investing Pro, Sanofi's fair value is $132.68, an upside of 36.65%. Sanofi's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out Sanofi's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or